PMC:7352545 / 44988-48096
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T385 | 185-190 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T386 | 400-405 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T387 | 447-452 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T388 | 459-471 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T389 | 531-546 | Body_part | denotes | plasma membrane | http://purl.org/sig/ont/fma/fma63841 |
T390 | 616-623 | Body_part | denotes | tissues | http://purl.org/sig/ont/fma/fma9637 |
T391 | 636-640 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T392 | 641-651 | Body_part | denotes | epithelium | http://purl.org/sig/ont/fma/fma9639 |
T393 | 691-707 | Body_part | denotes | epithelial cells | http://purl.org/sig/ont/fma/fma66768 |
T394 | 702-707 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T395 | 722-726 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T396 | 727-752 | Body_part | denotes | alveolar epithelial cells | http://purl.org/sig/ont/fma/fma62499 |
T397 | 747-752 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T398 | 996-1006 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T399 | 1061-1071 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T400 | 1323-1334 | Body_part | denotes | cytoplasmic | http://purl.org/sig/ont/fma/fma66835 |
T401 | 1350-1354 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
T402 | 1369-1379 | Body_part | denotes | chromosome | http://purl.org/sig/ont/fma/fma67093 |
T403 | 1838-1847 | Body_part | denotes | G protein | http://purl.org/sig/ont/fma/fma61788 |
T404 | 2023-2027 | Body_part | denotes | axis | http://purl.org/sig/ont/fma/fma12520 |
T405 | 2154-2162 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T406 | 2216-2220 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T407 | 2261-2271 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T408 | 3018-3022 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T13 | 335-359 | Body_part | denotes | renin-angiotensin system | http://purl.obolibrary.org/obo/UBERON_0018229 |
T14 | 361-364 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
T15 | 636-651 | Body_part | denotes | lung epithelium | http://purl.obolibrary.org/obo/UBERON_0000115 |
T16 | 636-640 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T17 | 641-651 | Body_part | denotes | epithelium | http://purl.obolibrary.org/obo/UBERON_0000483 |
T18 | 722-726 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T19 | 1335-1339 | Body_part | denotes | tail | http://purl.obolibrary.org/obo/UBERON_0002415 |
T20 | 1655-1661 | Body_part | denotes | organs | http://purl.obolibrary.org/obo/UBERON_0000062 |
T21 | 2216-2220 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T152 | 31-39 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T153 | 54-62 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T154 | 258-266 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T155 | 292-300 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T156 | 421-425 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T157 | 1257-1265 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T158 | 2054-2077 | Disease | denotes | cardiovascular diseases | http://purl.obolibrary.org/obo/MONDO_0004995 |
T159 | 2134-2142 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T160 | 2221-2227 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T161 | 2628-2631 | Disease | denotes | AT1 | http://purl.obolibrary.org/obo/MONDO_0008840 |
T162 | 2757-2765 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T163 | 2769-2777 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T164 | 2795-2813 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T165 | 2804-2813 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T166 | 2850-2858 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T603 | 110-115 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T604 | 160-161 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T605 | 179-190 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
T606 | 218-223 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T607 | 400-405 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T608 | 447-452 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T609 | 531-537 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T610 | 538-546 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T611 | 562-567 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T612 | 636-651 | http://purl.obolibrary.org/obo/UBERON_0000115 | denotes | lung epithelium |
T613 | 691-701 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T614 | 702-716 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells and type |
T615 | 722-726 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T616 | 722-726 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T617 | 736-746 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T618 | 747-752 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T619 | 832-833 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T620 | 950-951 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T621 | 952-960 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T622 | 996-1015 | http://purl.obolibrary.org/obo/CHEBI_33708 | denotes | amino acid residues |
T623 | 996-1015 | http://purl.obolibrary.org/obo/PR_000036907 | denotes | amino acid residues |
T624 | 1061-1080 | http://purl.obolibrary.org/obo/CHEBI_33708 | denotes | amino acid residues |
T625 | 1061-1080 | http://purl.obolibrary.org/obo/PR_000036907 | denotes | amino acid residues |
T626 | 1084-1085 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T627 | 1086-1092 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signal |
T628 | 1093-1100 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T629 | 1127-1128 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T630 | 1136-1144 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T631 | 1244-1245 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T632 | 1304-1305 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T633 | 1335-1339 | http://purl.obolibrary.org/obo/UBERON_0002415 | denotes | tail |
T634 | 1350-1354 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
T635 | 1412-1413 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T636 | 1414-1422 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T637 | 1438-1439 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T638 | 1655-1661 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organs |
T639 | 1668-1671 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T640 | 1710-1711 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T641 | 1729-1734 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T642 | 1745-1753 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T643 | 1838-1864 | http://purl.obolibrary.org/obo/PR_000030035 | denotes | G protein-coupled receptor |
T644 | 1866-1870 | http://purl.obolibrary.org/obo/PR_000030035 | denotes | GPCR |
T645 | 1879-1887 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activate |
T646 | 1977-1986 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T647 | 2031-2032 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T648 | 2216-2220 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T649 | 2216-2220 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T650 | 2231-2237 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T651 | 2252-2253 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T652 | 2261-2279 | http://purl.obolibrary.org/obo/CHEBI_33708 | denotes | amino acid residue |
T653 | 2261-2279 | http://purl.obolibrary.org/obo/PR_000036907 | denotes | amino acid residue |
T654 | 2458-2461 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T655 | 2462-2463 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T656 | 2537-2538 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T657 | 3018-3022 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1432 | 341-352 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T1433 | 361-364 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T1434 | 459-471 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T1435 | 719-721 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1436 | 996-1006 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T1437 | 996-1001 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T1438 | 1002-1006 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T1439 | 1023-1032 | Chemical | denotes | captopril | http://purl.obolibrary.org/obo/CHEBI_3380 |
T1440 | 1061-1071 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T1441 | 1061-1066 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T1442 | 1067-1071 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T1443 | 1093-1100 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T1444 | 1233-1242 | Chemical | denotes | N-glycans | http://purl.obolibrary.org/obo/CHEBI_59520 |
T1445 | 1235-1242 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T1446 | 1466-1477 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T1447 | 1505-1507 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1448 | 1513-1515 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1449 | 1535-1537 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1450 | 1628-1632 | Chemical | denotes | salt | http://purl.obolibrary.org/obo/CHEBI_24866|http://purl.obolibrary.org/obo/CHEBI_26710 |
T1452 | 1761-1763 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1453 | 1840-1847 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T1454 | 1974-1976 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1455 | 2154-2162 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T1456 | 2175-2177 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1457 | 2261-2279 | Chemical | denotes | amino acid residue | http://purl.obolibrary.org/obo/CHEBI_33708 |
T1458 | 2261-2271 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T1459 | 2261-2266 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T1460 | 2267-2271 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T1461 | 2289-2291 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1462 | 2305-2316 | Chemical | denotes | vasodilator | http://purl.obolibrary.org/obo/CHEBI_35620 |
T1463 | 2379-2381 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1464 | 2491-2505 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
T1465 | 2495-2505 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T1466 | 2602-2616 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
T1467 | 2606-2616 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T1468 | 2625-2627 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1469 | 2741-2751 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T1470 | 2929-2931 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1471 | 3041-3055 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
T1472 | 3045-3055 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T1473 | 3059-3073 | Chemical | denotes | Angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719 |
T1474 | 3071-3073 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T71 | 431-446 | http://purl.obolibrary.org/obo/GO_0044409 | denotes | entry into host |
T72 | 1597-1613 | http://purl.obolibrary.org/obo/GO_0042310 | denotes | vasoconstriction |
T73 | 1633-1642 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | retention |
T74 | 1977-1986 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T75 | 2585-2597 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
T76 | 2866-2873 | http://purl.obolibrary.org/obo/GO_0009606 | denotes | tropism |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T430 | 0-53 | Sentence | denotes | Structure and Role of the Host SARS-CoV Receptor ACE2 |
T431 | 54-86 | Sentence | denotes | SARS-CoV-2 needs ACE2 for entry. |
T432 | 87-217 | Sentence | denotes | Host proteases such as human ACE2 help viral entry through removement of a barrier to enter human cells through unknown receptors. |
T433 | 218-310 | Sentence | denotes | Human ACE2 is known for its role as the SARS-CoV-2 entry receptor and the SARS-CoV receptor. |
T434 | 311-406 | Sentence | denotes | The enzyme ACE-2 in the renin-angiotensin system (RAS) is associated with CoV entry into lungs. |
T435 | 407-507 | Sentence | denotes | ACE2 mediates SARS-2002 entry into host cells via S glycoprotein interaction with the ACE2 receptor. |
T436 | 508-580 | Sentence | denotes | The ACE2 levels on the plasma membrane correlate with virus infectivity. |
T437 | 581-652 | Sentence | denotes | ACE2 expression is present in most tissues such as the lung epithelium. |
T438 | 653-758 | Sentence | denotes | It is highly expressed by respiratory epithelial cells and type I/II lung alveolar epithelial cells [88]. |
T439 | 759-821 | Sentence | denotes | The host receptor is not linked to the classification of CoVs. |
T440 | 822-878 | Sentence | denotes | MERS-CoV, a β-CoV, does not recognize the ACE2 receptor. |
T441 | 879-941 | Sentence | denotes | In contrast, the α-CoV HCoV-NL63 recognizes the ACE2 receptor. |
T442 | 942-1045 | Sentence | denotes | ACE2 is a membrane-anchored carboxypeptidase with 805 amino acid residues and is captopril-insensitive. |
T443 | 1046-1340 | Sentence | denotes | It contains 17 amino acid residues as a signal peptide in the N-terminal region, a type I membrane-anchored domain in the C-terminal region, an extracellular N-terminal domain with heavy N-glycans, a N-terminal SARS-CoV-binding and carboxypeptidase site and a short C-terminal cytoplasmic tail. |
T444 | 1341-1385 | Sentence | denotes | The ACE2 gene is located on chromosome Xp22. |
T445 | 1386-1453 | Sentence | denotes | Two ACE2 forms are known, a membrane-bound form and a soluble form. |
T446 | 1454-1508 | Sentence | denotes | ACE cleaves angiotensin I (Ang I) substrate to Ang II. |
T447 | 1509-1662 | Sentence | denotes | Ang II recognizes the Ang II receptor type 1 (AT1R), contributing to systemic and local vasoconstriction, fibrosis and salt retention in vascular organs. |
T448 | 1663-1701 | Sentence | denotes | ACE2 has the opposite function of ACE. |
T449 | 1702-1739 | Sentence | denotes | ACE2 is a close homolog to human ACE. |
T450 | 1740-1808 | Sentence | denotes | ACE2 activity on Ang II is about 400-fold higher than that on Ang I. |
T451 | 1809-1987 | Sentence | denotes | Ang-1 to Ang-7 recognize the G protein-coupled receptor (GPCR) Mas to activate vasorelaxation, cardioprotection, antioxidative action, antiinflammation and anti-Ang II-signaling. |
T452 | 1988-2078 | Sentence | denotes | Therefore, the ACE2-Ang-1 to Ang-7 axis is a target candidate for cardiovascular diseases. |
T453 | 2079-2143 | Sentence | denotes | ACE2 shows similar binding structures between nCoV and SARS-CoV. |
T454 | 2144-2238 | Sentence | denotes | The three proteins of ACE, Ang II and AT1R contribute to progression of lung injury in humans. |
T455 | 2239-2336 | Sentence | denotes | ACE2 removes a single amino acid residue from Ang II to yield the vasodilator, named Ang 1-Ang 7. |
T456 | 2337-2400 | Sentence | denotes | ACE2 cleaves Ang-I to Ang 1–Ang 9 and Ang II to Ang-1 to Ang-7. |
T457 | 2401-2506 | Sentence | denotes | The biggest difference between ACE2 and ACE is that ACE2 has a non-inhibitory property by ACE inhibitors. |
T458 | 2507-2598 | Sentence | denotes | Pulmonary ACE2 is potentially a candidate target in CoV-involved inflammatory pathogenesis. |
T459 | 2599-2681 | Sentence | denotes | If ACE inhibitors and Ang II-AT1 blockers are dosed, ACE2 expression is increased. |
T460 | 2682-2786 | Sentence | denotes | However, currently we have no conclusive evidence that the inhibitors help SARS-CoV or SARS-CoV-2 entry. |
T461 | 2787-2838 | Sentence | denotes | Rather, SARS-CoV infection reduces ACE2 expression. |
T462 | 2839-2908 | Sentence | denotes | Therefore, SARS-CoV-2 host tropism is not related to ACE2 expression. |
T463 | 2909-2983 | Sentence | denotes | ACE2 levels and ANG II/ANG 1–7 levels regulate the pathogenic progression. |
T464 | 2984-3108 | Sentence | denotes | ACE2 expression is upregulated by gene polymorphisms and ACE inhibitors or Angiotensin II receptor blockers such as sartans. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32604730-32305506-51944046 | 754-756 | 32305506 | denotes | 88 |
T75465 | 754-756 | 32305506 | denotes | 88 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T13 | 2054-2077 | Phenotype | denotes | cardiovascular diseases | http://purl.obolibrary.org/obo/HP_0001626 |